Le Lézard
Classified in: Science and technology
Subjects: AWD, WOM

Navisite Announces Winners of Second Annual Steminist Scholarship Program in India Supporting Young Women in STEM


Three winners will each receive 1,00,000 INR to put towards their university education in STEM

GURUGRAM, India, March 12, 2024 /PRNewswire/ -- Navisite, part of Accenture, today announced the three winners of its second annual Navisite's Next Steminist scholarship program in India. The program is designed to help close the gender gap in technology and encourage young women to pursue their dreams in STEM (science, technology, engineering, and math). The three winners are Nisha Khati from Bengaluru, Karnataka; Anchal Mourya from Prayagraj, Uttar Pradesh; and Bhanu Yadavalli from Khammam, Telangana. Each winner will receive 1,00,000 INR to put towards their university education in STEM.

"We're thrilled to recognize these accomplished and deserving young women in our second annual Steminist India scholarship program," said Tejal Munagekar, managing director of Navisite India, part of Accenture. "It is our honor to be able to support their educational goals with financial assistance as they embark on their journeys and work to achieve their career aspirations in STEM."

Since Navisite's Steminist scholarship program launched in the U.S. in 2021, the company has awarded nearly $100,000 in scholarships. In 2022, Navisite expanded the program to India, offering two needs-based scholarships to eligible female candidates who are currently enrolled full-time at an accredited college or university. This year, the company expanded the program to honor three women.

The three winners plan to use the scholarship towards their education in data engineering, medicine, and software engineering, respectively:

For more information on the program, please visit Navisite's Next Steminist web page.

About Navisite

Navisite, a part of Accenture, is a trusted digital transformation partner for growing and established global brands. Through our highly specialized teams, industry solutions, business process expertise, and application services, we provide the capabilities and practical guidance customers need to modernize, build, and support more agile, resilient, and expanding businesses. Our strategic advisory and transformation services advance innovation with comprehensive cloud, enterprise application, data management, intelligent automation and cybersecurity solutions, empowering customers to navigate change and meet new demands at any point in their journey. To learn more, visit navisite.com.? 

SOURCE Navisite, part of Accenture


These press releases may also interest you

at 03:29
Ericsson's annual general meeting on April 3, 2024 authorized the company to, in conjunction with the delivery of vested shares under the long-term variable compensation program 2021 ("LTV 2021"), prior to the annual general meeting in 2025, retain...

at 03:21
W3 Energy and Schierloh Engineering Group are pleased to announce a collaborative partnership to enhance the technical operation of wind farms across Germany. This strategic alliance will enable Schierloh Engineering GmbH to ensure uninterrupted...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:38
Sivers Semiconductors AB (STO: SIVE), a leading supplier of integrated chips and modules for advanced communications and sensor solutions for AI Photonics, SATCOM and 5G/6G today reported its first-quarter results for the fiscal year 2024. The...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...



News published on and distributed by: